Overview
Shlomo Shinnar is a Pediatric Neurologist practicing medicine in Bronx, New York.
Dr. Shinnar is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Genetic Epilepsy with Febrile Seizures Plus (GEFS+), Status Epilepticus, Seizures, and Epilepsy.
He is actively involved in clinical research, co-authoring 116 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
111 E 210th St, Bronx, NY 10467
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Children's Hospital At Montefiore
Solomon L. Moshé, MD, is Vice Chair of Neurology, Director of the Isabelle Rapin Child Neurology Division and Director of Clinical Neurophysiology at Montefiore. He is also the Charles Frost Chair in Neurosurgery and Neurology, Vice Chair, Saul R. Korey Department of Neurology, and Professor of Neurology, Neuroscience and Pediatrics at the Albert Einstein College of Medicine (Einstein). Dr. Moshé’s clinical focus is on epilepsy and electroencephalography with special emphasis on age-related influences on the expression, control and consequences of seizures. Dr. Moshe is highly rated in 13 conditions, according to our data. His clinical expertise encompasses West Syndrome, Spasmus Nutans, Epilepsy, and Genetic Epilepsy with Febrile Seizures Plus (GEFS+). Dr. Moshe is currently accepting new patients.
The Children's Hospital At Montefiore
Elissa G. Yozawitz, MD, is Director of Neonatal Neurology at Children’s Hospital at Montefiore Einstein and Professor of Neurology and Pediatrics at our Albert Einstein College of Medicine. Dr. Yozawitz focuses on the neurological management of children, from the neonatal period through adolescence, particularly those with difficult-to-treat seizures. She also specializes in the diagnosis and treatment of hypoxic-ischemic encephalopathy, stroke and seizures in the newborn. Dr. Yozawitz’s expertise includes electroencephalography (EEG) and state-of-the-art treatments. Dr. Yozawitz is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses West Syndrome, Epilepsy in Children, Spasmus Nutans, and Epilepsy. Dr. Yozawitz is currently accepting new patients.
CUIMC/Harkness Pavilion
Dr. Chiriboga is Professor of Neurology and Pediatrics at CUIMC and former Interim Director of the Division of Child Neurology, Departments of Neurology and Pediatrics, Vagelos College of Physicians and Surgeons. She is also former Chief of Pediatric Neurology at Columbia University's affiliate hospital, Harlem Hospital Center.Dr. Chiriboga was born in Peru and educated in Argentina, where she graduated with Honors from the Faculty of Medicine at the National University of Buenos Aires in 1982. Dr. Chiriboga completed training in pediatrics at St. Luke's-Roosevelt Hospital in 1985. After completing her training in child neurology in 1988 at the Neurological Institute and Babies Hospital of Columbia-Presbyterian Medical Center, Dr. Chiriboga joined the Division of Child Neurology at NewYork-Presbyterian/Columbia University Irving Medical Center. Subsequently, she completed a Neuroepidemiology fellowship at the Gertrude H. Sergievsky Center and received a Master in Public Health from the Mailman School of Public Health, Columbia University. Dr. Chiriboga serves/has served on committees of the NIH, CNS, and ABPN. She is a diplomate of the ABPN in Child Neurology.Dr. Chiriboga's current research focuses on Spinal Muscular Atrophy (SMA) clinical trials. Past areas of research, including NIH funding, has focused on congenital infections and neurodevelopmental disorders, including cerebral palsy and effects of perinatal exposures. Her clinical practice focuses on neuromuscular disorders as well as developmental, neurobehavioral neurology, and migraine, and on the treatment of spasticity. Dr. Chiriboga is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 2, and Spinal Muscular Atrophy Type 1. Dr. Chiriboga is board certified in Neurology With Special Qualification In Child Neurology and Child Neurology. Dr. Chiriboga is currently accepting new patients.
CUIMC/Harkness Pavilion
Jennifer Bain, MD, PhD, is an Associate Professor of Neurology and Pediatrics at the Columbia University Medical Center. Dr. Bain completed both an MD and PhD, as well as general pediatrics residency at Rutgers – New Jersey Medical School in New Jersey. She then trained in Child Neurology at NewYork-Presbyterian/Columbia University Irving Medical Center in New York City and is a board-certified neurologist with special certification in Child Neurology seeing both inpatient and outpatient pediatric neurology patients. Her clinic focuses on diagnosis and management of autism, cerebral palsy and neurodevelopmental disorders in addition to genetic disorders associated with such conditions.Her early research career focused on spinal cord and brain development after injuries such as spinal cord injury and perinatal hypoxic ischemic encephalopathy. During her residency training, her clinical research focused on studying autonomic dysfunction in children with autism spectrum disorders and neurological complications during extracorporeal membrane oxygenation. She currently works as a physician scientist at Columbia University specializing in general pediatric neurology with expertise in development, behavioral neurology, autism and cerebral palsy. Her clinical research has focused on studying the genetics of neurodevelopmental disorders including autism and cerebral palsy. The genes she has worked closely on include HNRNPH2 and related disorders, GRIN disorders, KIF1A. She is interested in understanding clinically meaningful measures in families affected by neurodevelopmental disorders and measuring longitudinal trajectories in such disorders. She has been working closely with several patient advocacy groups, researchers, and Simons Searchlight to continuously move forward in the understanding of the developing and aging brain. Dr. Bain is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses HNRNPH2-Related Disorder, Autism Spectrum Disorder, Cerebral Palsy, and Early Infantile Epileptic Encephalopathy. Dr. Bain is board certified in Neurology With Special Qualification In Child Neurology. Dr. Bain is currently accepting new patients.
The Children's Hospital At Montefiore
Aleksandra Djukic, is Associate Professor of Neurology . She completed her neurology residency at the Albert Einstein College of Medicine. She is a diplomate of the American Board of Psychiatry and Neurology. Dr. Jacobs is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Rett Syndrome. Dr. Jacobs is currently accepting new patients.
CUIMC/Harkness Pavilion
"Tristan T. Sands, MD, PhD is Assistant Professor in the Columbia University Vagelos College of Physicians & Surgeons (Columbia VP&S) Departments of Neurology and Pediatrics. He is a pediatric neurologist who treats children and babies suffering from epilepsy and a physician scientist with expertise in genetic causes of epilepsy and neurodevelopmental disease. Dr. Sands completed his MD-PhD at Columbia VP&S through a Medical Scientist Training Program with thesis work in lab of Dr. Arnold Kriegstein. During child neurology residency at UCSF, Dr. Sands trained in electroclinical phenotyping of the epilepsies under Dr. M. Roberta Cilio. After finishing his clinical training at Columbia VP&S in epilepsy and clinical neurophysiology with Dr. Jim Riviello, Dr. Sands joined Columbia VP&S as faculty in 2017, first training in neurogenetics at the Institute for Genomic Medicine, and then returning to the bench to study genetic epilepsy using mouse models under the mentorship of Dr. Wayne Frankel. Dr. Sands has worked closely with families to treat hundreds of children with epilepsy. He is the author of chapters on pediatric epilepsy and genetic epilepsy in major textbooks in the field of neurology, including Merritt’s Neurology and Swaiman’s Pediatric Neurology. Dr. Sands has served as an expert on ClinGen’s epilepsy gene curation panel since 2017. In 2023, Dr. Sands was named Fellow of the American Epilepsy Society in recognition of professional accomplishment and dedication in the field of epilepsy. Dr. Sands is a 2024 Louis V. Gerstner Scholar. His research contributions include demonstration of the exquisite efficacy of carbamazepine for neonatal epilepsy caused by inherited loss-of-function variants in KCNQ2 and KCNQ3, work that led to changes to the International League against Epilepsy guidelines and recommendations on the treatment of seizures in newborn babies. Dr. Sands reported the electroclinical characterization of a new gain-of-function phenotype caused by de novo variants in KCNQ3. Dr. Sands reported variants in NBEA as a cause epilepsy and neurodevelopment, and he characterized the largest cohort of patients with epilepsy and neurodevelopmental disability caused by pathogenic variants in CSNK2B. The Sands ""END (Epilepsy & Neurodevelopmental Disease) Laboratory,"" established in 2022 in the Center for Translational Research in Neurodevelopmental Disease (CTRND), uses mouse and human cellular models to identify convergent disease mechanisms and novel therapeutic strategies for epilepsy and encephalopathy caused by rare genetic mutations. These research efforts are supported by federal grants from both NIH and private agencies.". Dr. Sands is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Epilepsy in Children, Epilepsy, Seizures, and Status Epilepticus. Dr. Sands is board certified in Epilepsy, Neurology With Special Qualification In Child Neurology, and Clinical Neurophysiology. Dr. Sands is currently accepting new patients.
Frequently Asked Questions about Dr. Shlomo Shinnar
How do I make an appointment with Dr. Shlomo Shinnar?
You can book an appointment with Dr. Shlomo Shinnar by calling their office at 718-920-4378. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Shlomo Shinnar a top-rated expert for Genetic Epilepsy with Febrile Seizures Plus (GEFS+)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shlomo Shinnar is classified as an Elite expert for Genetic Epilepsy with Febrile Seizures Plus (GEFS+), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Shlomo Shinnar specialize in?
While Dr. Shlomo Shinnar is a Pediatric Neurology, they have specific expertise in Genetic Epilepsy with Febrile Seizures Plus (GEFS+), Status Epilepticus, and Seizures. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Neurology.
Does Dr. Shlomo Shinnar participate in research or clinical trials?
Yes. Dr. Shlomo Shinnar has published 115 articles and abstracts on conditions like Genetic Epilepsy with Febrile Seizures Plus (GEFS+). You can view a list of Dr. Shlomo Shinnar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Shlomo Shinnar accept my insurance?
Dr. Shlomo Shinnar accepts most major insurance plans, including Humana. We recommend calling the office directly at 718-920-4378 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Genetic Epilepsy with Febrile Seizures Plus (GEFS+)
- Status EpilepticusDr. Shinnar isElite. Learn about Status Epilepticus.
- Distinguished
- EpilepsyDr. Shinnar isDistinguished. Learn about Epilepsy.
- Epilepsy Juvenile AbsenceDr. Shinnar isDistinguished. Learn about Epilepsy Juvenile Absence.
- SeizuresDr. Shinnar isDistinguished. Learn about Seizures.
- Advanced
- Absence SeizureDr. Shinnar isAdvanced. Learn about Absence Seizure.
- Epilepsy in ChildrenDr. Shinnar isAdvanced. Learn about Epilepsy in Children.
- Generalized Tonic-Clonic SeizureDr. Shinnar isAdvanced. Learn about Generalized Tonic-Clonic Seizure.
- West SyndromeDr. Shinnar isAdvanced. Learn about West Syndrome.
- Experienced
- Autism Spectrum DisorderDr. Shinnar isExperienced. Learn about Autism Spectrum Disorder.
- Epilepsy with Myoclonic-Atonic SeizuresDr. Shinnar isExperienced. Learn about Epilepsy with Myoclonic-Atonic Seizures.
- Myoclonic EpilepsyDr. Shinnar isExperienced. Learn about Myoclonic Epilepsy.
- Partial SeizureDr. Shinnar isExperienced. Learn about Partial Seizure.
- Spasmus NutansDr. Shinnar isExperienced. Learn about Spasmus Nutans.





